- PMID: 36614303
- DOI: 10.3390/ijms24010859
Abstract
Melanoma is deadly, physically impairing, and has ongoing treatment deficiencies. Current treatment regimens include surgery, targeted kinase inhibitors, immunotherapy, and combined approaches. Each of these treatments face pitfalls, with diminutive five-year survival in patients with advanced metastatic invasion of lymph and secondary organ tissues. Polyphenolic compounds, including cannabinoids, terpenoids, and flavonoids; both natural and synthetic, have emerging evidence of nutraceutical, cosmetic and pharmacological potential, including specific anti-cancer, anti-inflammatory, and palliative utility. Cannabis sativa is a wellspring of medicinal compounds whose direct and adjunctive application may offer considerable relief for melanoma sufferers worldwide. This review aims to address the diverse applications of C. sativa‘s biocompounds in the scope of melanoma and suggest it as a strong candidate for ongoing pharmacological evaluation.
Keywords: CBD, Cannabis sativa, THC, anti-cancer, cannabinoids, flavonoids, inflammation, melanoma, terpenoids
Similar articles
-
Evaluating Cannabis sativa L.’s neuroprotection potential: From bench to bedside.
Phytomedicine. 2022 Dec;107:154485. doi: 10.1016/j.phymed.2022.154485. Epub 2022 Sep 29.PMID: 36209703 Review. -
Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018.PMID: 30627539 Free PMC article. Review.
-
Curr Pharm Des. 2021;27(13):1564-1578. doi: 10.2174/1381612826666201202125807.PMID: 33267756 Review.
-
Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
Behav Pharmacol. 2022 Apr 1;33(2&3):130-157. doi: 10.1097/FBP.0000000000000627.PMID: 33709984 Review. -
Phytochemistry of Cannabis sativa L.
Prog Chem Org Nat Prod. 2017;103:1-36. doi: 10.1007/978-3-319-45541-9_1.PMID: 28120229 Review.